We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INFY:NYSEInfosys Limited Analysis

Data as of 2026-07-23 - not real-time

$10.93

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Infosys is trading at $10.93, comfortably above the 30‑day support of $10.34 but well below its 20‑day SMA of $11.02 and 50‑day SMA of $11.69, indicating a short‑term bearish bias. Technical signals show a bearish trend direction, yet the MACD histogram is positive, hinting at a potential near‑term bounce. Fundamentally, the stock appears undervalued with a trailing P/E of 14 versus an industry average of 34 and a DCF‑derived fair value of $14.06, implying roughly 20% upside. The company delivers a robust 4.69% dividend yield on a 64% payout ratio, supported by $3.17 bn of free cash flow and a 31% ROE, suggesting dividend sustainability. Revenue is growing at 6.6% YoY and operating margins sit near 21%, reinforcing a solid earnings base. However, volatility is high at nearly 50% over the past month, though beta is modest at 0.47, reflecting limited market‑wide sensitivity. Upcoming Q1 FY27 results add earnings uncertainty, which could swing the stock in either direction in the near term.
Long‑run, Infosys benefits from AI‑focused service expansions and a diversified client base across multiple industries, positioning it for steady growth. The combination of a low beta, stable liquidity (average daily volume ~22.5 M shares), and a strong balance sheet (cash > $3.7 bn, debt under $1 bn) mitigates many risks, while the attractive dividend and valuation cushion provide downside protection for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish SMA alignment
  • Upcoming earnings release adds near‑term uncertainty
  • High 30‑day volatility despite low beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to peers and DCF fair value
  • Strong cash generation and sustainable dividend yield
  • Projected earnings growth from AI and digital services

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust ROE and operating margins supporting durable profitability
  • Strategic positioning in high‑growth AI and cloud services
  • Low beta and solid balance sheet offering resilience over time

Key Metrics & Analysis

Financial Health

Revenue Growth6.60%
Profit Margin16.43%
P/E Ratio14.0
ROE31.44%
ROA15.09%
Debt/Equity9.83
P/B Ratio9.0
Op. Cash Flow$4.0B
Free Cash Flow$3.2B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI44.6
Support$10.34
Resistance$11.58
MA 20$11.02
MA 50$11.69
MA 200$14.87
MACDBullish
VolumeStable
Fear & Greed Index90.45

Valuation

Fair Value$14.06
Target Price$13.11
Upside/Downside19.90%
GradeUndervalued
TypeBlend
Dividend Yield4.69%

Risk Assessment

Beta0.47
Volatility49.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.